Your session is about to expire
← Back to Search
Brain Stimulation for Schizophrenia
Study Summary
This trial will test if a non-invasive brain stimulation can help reduce symptoms in people with schizophrenia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have struggled with drug or alcohol addiction in the past six months.I have epilepsy.You have metal implants in your body.I have skin conditions like eczema where electrodes would be placed.I can understand and agree to the study's details on my own.You have a condition called mental retardation.You have a device called a defibrillator implanted in your body.I have a brain condition.I have experienced a head injury.I have a history of neurological or severe psychiatric disorders.You have vision problems that make it difficult for you to complete cognitive tests, especially if you have trouble seeing colors accurately.I am not fully hospitalized and can manage some daily activities.I am 18 years old or older.I have been diagnosed with schizophrenia or a related disorder.You have a pacemaker.You have used drugs or alcohol excessively in the past month.You have implanted devices in your brain or spine that send electrical signals.
- Group 1: dlPFC/TPJ Stimulation + Rest
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this investigation allow for participation of seniors aged 75 or above?
"The cut-off for participation in this trial is 65 years old, so it does not include minors. However, there are 46 clinical trials available to patients who fall below 18 and 164 that cater to those over the age of 65."
Is it possible for me to participate in this clinical experiment?
"Participants for this study are limited to 15 adults, between the age of 18 and 65, who have been diagnosed with schizophrenia. Additionally, all potential enrollees must be over 18 years old and possess a relatively stable mental health status as outpatient or partial hospital patients."
Is the recruitment of participants ongoing for this investigation?
"This clinical research is actively recruiting patients, with data hosted on the official website indicting that it was posted initially on September 14th 2021 and revised most recently on November 22nd 2021."
What is the patient enrollment quota for this clinical investigation?
"Affirmative, the information hosted on clinicaltrials.gov verifies that this medical study is actively searching for participants. The trial was first listed on September 14th 2021 and most recently updated on November 22nd 2021. A total of 15 patients must be recruited from one location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Average response time
- < 1 Day
Most responsive sites:
- Imaging Research Center: < 24 hours
Typically responds via
Share this study with friends
Copy Link
Messenger